Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study (Q34579641)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study |
scientific article |
Statements
1 reference
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study (English)
1 reference
Alessandro Morabito
1 reference
Cesare Gridelli
1 reference
Fortunato Ciardiello
1 reference
Domenico Galetta
1 reference
Teresa Gamucci
1 reference
Ciro Gallo
1 reference
Anna Ceribelli
1 reference
Vittorio Gebbia
1 reference
Francesco Carozza
1 reference
Adolfo Favaretto
1 reference
Bruno Daniele
1 reference
Santi Barbera
1 reference
Francesco Rosetti
1 reference
Antonio Rossi
1 reference
Paolo Maione
1 reference
Francesco Cognetti
1 reference
Antonio Testa
1 reference
Massimo Di Maio
1 reference
Francesco Perrone
1 reference
GECO investigators
1 reference
1 June 2007
1 reference
1 reference
8
1 reference
6
1 reference
500-512
1 reference
Identifiers
1 reference
1 reference